Resources
- sort by:
- Relevance
- Date
- Popularity
- Bausch & Lomb-Pharmos Lenoxin agreement. (Bausch & Lomb Pharmaceuticals Inc.) (Brief Article)
- Pharmos Corporation [NASDAQ NMS: PARS] has signed a letter of intent with Bausch & Lomb Pharmaceuticals, Inc, a division of Bausch & Lomb, Inc to cooperate on the further development, production, distribution, marketing and promotion of Lenox Pharmos Corporation [NASDAQ NMS: PARS] has signed a letter...
- Research articles 1994-05-13
- Advanced Medical Done With Bausch
- AS SEEN ON OCBJ.COM Santa Ana-based Advanced Medical Optics Inc. last week ended its $4.23 billion bid to take over rival Bausch & Lomb Inc. In a letter to Bausch directors, Chief Executive James Mazzo said Advanced Medical was disappointed that Bausch' s board would not grant it...
- Research articles 2007-08-06
- Rival withdraws bid for Bausch & Lomb
- Rival Withdraws Bid for Bausch & Lomb. Advanced Medical Optics Inc. Santa Ana CA withdrew its $4.2 billion buyout bid for rival eye care products maker Bausch & Lomb Inc. Rochester NY, clearing the way for Bausch to be acquired by private equity firm Warburg Pincus New York...
- Research articles 2007-08-06
- Bausch & Lomb Receives Acquisition Proposal from Advanced Medical Optics for $75.00 Per Share in Cash and AMO Stock
- ROCHESTER, N.Y. -- Bausch & Lomb (NYSE:BOL) announced today that it has received from Advanced Medical Optics (NYSE:EYE) a proposal (the "AMO Proposal") to acquire 100% of the outstanding shares of Bausch & Lomb in a merger in which Bausch & Lomb's shareholders would receive, per share of Bausch &...
- Research articles 2007-07-05
- Bausch and Lomb licensed for Levi's sunglasses.
- BAUSCH & LOMB LICENSED FOR LEVI'S SUNGLASSES NEW YORK -- Bausch & Lomb has signed a licensing pact with Levi Strauss & Co. to produce a line of sunglasses under the Levi's name. The sunglasses will be introduced for sale...
- Research articles 1989-06-29
- Idea Integration redesigns Bausch & Lomb's website
- TELECOMWORLDWIRE-18 August 2006-Idea Integration redesigns Bausch & Lomb's websiteC1994-2006 M2 COMMUNICATIONS LTD http://www.m2.com Idea Integration, a technology solutions unit of MPS Group, Inc (NYSE: MPS), announced on Thursday (17 August) the relaunch of eye health company Bausch & Lomb's website. The newly designed website, available at http://www.bausch.com, is...
- Research articles 2006-08-18
- Shareholders alert for BAUSCH LOMB INC.
- M2 PRESSWIRE-16 May 2007-bellwetherreport.com: Shareholders alert for BAUSCH LOMB INCC1994-2007 M2 COMMUNICATIONS LTD RDATE:16052007 Shareholders alert for BAUSCH LOMB INC (NYSE:BOL) Eyes are the windows to profit for Bausch & Lomb. The diverse company is best known as a...
- Research articles 2007-05-16
- Current Research on BAUSCH LOMB INC.
- M2 PRESSWIRE-24 May 2007-Biotech News: Current Research on BAUSCH LOMB INCC1994-2007 M2 COMMUNICATIONS LTD RDATE:24052007 Current Research on BAUSCH LOMB INC (NYSE:BOL) Eyes are the windows to profit for Bausch & Lomb. The diverse company is best known as...
- Research articles 2007-05-24
- Bausch and Lomb.(PLMA COMPANY PROFILES)
- Bausch & Lomb is your source for private label sterile prescription Rx and OTC ophthalmic and contract manufacturing. Bausch & Lomb, headquartered in Rochester, N.Y., is the eye health company dedicated to perfecting vision and enhancing life for consumers around the world. The Bausch & Lomb...
- Research articles 2008-10-01
- Bausch & Lomb Encourages Wesley Jessen Shareholders to Tender Shares
- Business Editors ROCHESTER, N.Y.--BUSINESS WIRE--May 25, 2000 Bausch & Lomb (NYSE:BOL) is encouraging Wesley Jessen VisionCare (Nasdaq:WJCO) shareholders to tender their shares into the Bausch & Lomb tender offer, which expires at 6:00 p.m. Eastern Time, Wednesday, May 31, 2000. The company reiterated that, if by May 31,...
- Research articles 2000-05-25
- LCA-Vision Announces Branding Partnership With Bausch & Lomb; ``LasikPlus, a Bausch & Lomb Laser Center'' Unveiled in Cincinnati
- Business Editors & Health/Medical Writers CINCINNATI--BW HealthWire--Sept. 10, 2001 LCA-Vision Inc. (Nasdaq:LCAV) (Nasdaq Europe: LCAV), a leading provider of laser vision correction services across the U.S., today announced a branding partnership with Bausch & Lomb (NYSE:BOL). As part of this alliance, LCA-Vision has named the Company's flagship...
- Research articles 2001-09-10
- Bausch & Lomb Sues Ciba Vision for Patent Infringement; Asks Federal Court to Halt Ciba's Upcoming Launch of Infringing Extended Wear Contact Lens in the U.S
- Business Editors ROCHESTER, N.Y.--BUSINESS WIRE--November 7, 2001 Bausch & Lomb (NYSE:BOL) has filed a lawsuit against Ciba Vision Corporation for infringement of Bausch & Lomb's patent rights to extended wear soft contact lenses. The U.S. Patent and Trademark Office of the Department of Commerce issued Bausch &...
- Research articles 2001-11-07
- Bausch & Lomb confirms global alliance with InSite Vision
- ROCHESTER, N.Y.--BUSINESS WIRE--July 23, 1996--Bausch & Lomb (NYSE: BOL) today announced a global alliance with InSite Vision Incorporated (NASDAQ: INSV). As part of the alliance, Bausch & Lomb will co-develop and manufacture certain glaucoma products based on InSite's proprietary DuraSiteR ophthalmic drug delivery technology. The alliance also grants Bausch...
- Research articles 1996-07-23
- BAUSCH & LOMB RETAINS CB COMMERCIAL REAL ESTATE GROUP TO MARKET GARRETT COUNTY, MD. MANUFACTURING PLANT; Unique Assignment Involves Aggressive National Marketing Campaign Targeting Firms Interested in Re-Employing Company Workers
- ROCHESTER, N.Y.--BUSINESS WIRE--Bausch & Lomb (NYSE/BOL) Global healthcare and optical products manufacturer Bausch & Lomb announced today its selection of CB Commercial Real Estate Group, the world's largest provider of diversified real estate services, as exclusive marketing company to secure the sale of its sunglass lens factory, in Oakland, Md.,...
- Research articles 1996-03-25
- Bausch & Lomb and Alcon Laboratories, Inc. Settle Eye Vitamin Patent Dispute
- ROCHESTER, N.Y. -- Bausch & Lomb (NYSE:BOL) announces a settlement agreement ending a patent dispute relating to Alcon's ICAPSR AREDS product. The agreement establishes a cross-licensing relationship that permits Alcon to continue to sell its AREDS-based nutraceutical product worldwide, and grants Bausch & Lomb global rights under one or more...
- Research articles 2005-03-18
- Bausch & Lomb eyes skin care opportunity.(INTERNATIONAL NEWS)(Bausch & Lomb Inc.)(Brief article)
- Bausch & Lomb, the French eyewear and contact lens specialist, is making a move into the skin care sector with the launch of its first range of topical eye care products. Bausch & Lomb, the French eyewear and contact lens specialist, is making a...
- Research articles 2006-04-21
- Bausch & Lomb Licenses rPlasmin from Talecris Biotherapeutics for Ophthalmic Use
- ROCHESTER, N.Y. and RESEARCH TRIANGLE PARK, N.C. -- Bausch & Lomb (NYSE:BOL) and Talecris Biotherapeutics announced today that Talecris has granted an exclusive worldwide license to Bausch & Lomb for recombinant Plasmin technology for use in ophthalmology. The companies will co-develop rPlasmin, a recombinant derivative of the human blood component...
- Research articles 2006-08-29
- Bausch & Lomb Files Preliminary Proxy Statement for Merger Agreement with Warburg Pincus
- ROCHESTER, N.Y. -- Bausch & Lomb (NYSE: BOL) has filed a preliminary proxy statement with the Securities and Exchange Commission ("SEC") for a special meeting of shareholders to be held to consider Bausch & Lomb's pending merger agreement with affiliates of Warburg Pincus. As previously announced on May 16, 2007,...
- Research articles 2007-07-10
- Bausch & Lomb Teams with Novartis Ophthalmics To Co-Promote Bausch & Lomb Retisert™
- ROCHESTER, N.Y. -- Bausch & Lomb (NYSE:BOL) and Novartis Ophthalmics, a business unit of Novartis Pharmaceutical Corp. (NYSE: NVS), will co-promote Bausch & Lomb's patented orphan drug RetisertTM fluocinolone acetonide intravitreal implant 0.59 mg, in the United States. Retisert is indicated for the treatment of chronic noninfectious posterior segment uveitis.
- Research articles 2006-02-09
- Bausch & Lomb Announces Entry Into Agreement to Sell $650 Million of Notes
- ROCHESTER, N.Y. -- In connection with the merger agreement between WP Prism Inc., Bausch & Lomb Incorporated (NYSE: BOL) ("Bausch & Lomb") and WP Prism Merger Sub Inc. ("Merger Sub") regarding the acquisition of Bausch & Lomb, Merger Sub today announced that it has entered into an agreement to sell...
- Research articles 2007-10-16
- << Previous
- page 1 of 60
- Next >>
